There were no clinically pertinent alterations in comparison to 2011 except for new information and new recommendations with regards to the procedure with bisphosphonates and denosumab (see section ‘Bisphosphonates and RANKL Antibody Denosumab’).Strengthen irradiation in the course of postmastectomy irradiation has no impact on breast cancer-pa